Elisabeth Perzborn
- Cardiology and Cardiovascular Medicine top 0.5%
- Internal Medicine top 0.1%
- Hematology top 1%
- Physiology top 5%
- Molecular Biology
- Co-authors
- Susanne RoehrigAlexander StraubVolker LauxDagmar KubitzaJens PohlmannStefan HeitmeierM SamamaCéline Guinet
- Topics
- Atrial Fibrillation Management and Outcomes (34 papers)Venous Thromboembolism Diagnosis and Management (28 papers)Blood Coagulation and Thrombosis Mechanisms (26 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Elisabeth Perzborn
69 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 121
- Cardiology and Cardiovascular Medicine 2.8k
- Internal Medicine 2.0k
- Hematology 841
- Physiology 711
- Molecular Biology 614
Countries citing papers authored by Elisabeth Perzborn
This map shows the geographic impact of Elisabeth Perzborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Perzborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Perzborn more than expected).
Fields of papers citing papers by Elisabeth Perzborn
This network shows the impact of papers produced by Elisabeth Perzborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Perzborn. The network helps show where Elisabeth Perzborn may publish in the future.
Co-authorship network of co-authors of Elisabeth Perzborn
This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Perzborn. A scholar is included among the top collaborators of Elisabeth Perzborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Perzborn. Elisabeth Perzborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 60 | |
| 2 | 67 | |
| 3 | 73 | |
| 4 | 25 | |
| 5 | Anti-Factor Xa chromogenic assay for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicentre field trial | 1 |
| 6 | 11 | |
| 7 | 201 | |
| 8 | 232 | |
| 9 | 366 | |
| 10 | 49 | |
| 11 | 58 | |
| 12 | 469 | |
| 13 | 251 | |
| 14 | 116 | |
| 15 | 106 | |
| 16 | 459 | |
| 17 | 20 | |
| 18 | 2 | |
| 19 | Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid. | 8 |
| 20 | 50 |
About Elisabeth Perzborn
Elisabeth Perzborn is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 70 papers that have together received 4.4k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (34 papers), Venous Thromboembolism Diagnosis and Management (28 papers) and Blood Coagulation and Thrombosis Mechanisms (26 papers). The work is most often cited by research in Internal Medicine (2.0k citations), Cardiology and Cardiovascular Medicine (2.8k citations) and Hematology (841 citations). Elisabeth Perzborn has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Susanne Roehrig, Alexander Straub, Volker Laux, Dagmar Kubitza, Jens Pohlmann, Stefan Heitmeier, M Samama, Céline Guinet, Frank Misselwitz and Matthias Schramm. Their work appears in journals such as Nature, Blood and Nature Reviews Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.